| Umadevi Senguttuvan, PHD | |
|
44000 Old Warm Springs Blvd, Fremont, CA 94538-6145 | |
| (510) 246-7547 | |
| Not Available |
| Full Name | Umadevi Senguttuvan |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 44000 Old Warm Springs Blvd, Fremont, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083941660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Umadevi Senguttuvan, PHD 44000 Old Warm Springs Blvd, Fremont, CA 94538-6145 Ph: (510) 246-7547 | Umadevi Senguttuvan, PHD 44000 Old Warm Springs Blvd, Fremont, CA 94538-6145 Ph: (510) 246-7547 |
News Archive
The Washington Post reports that regulators are "trying to resolve" which insurance plans must comply with the health law's new requirements. "In keeping with President Obama's promise that you can hold on to your insurance if you like it, the new law exempts existing health plans from many of its provisions. But the law leaves it to regulators to decide how much a health plan can change without giving up its grandfathered status."
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.
Endoplasmic reticulum stress is closely involved in the early stage of diabetic retinopathy. According a study published in the Neural Regeneration Research (Vol. 8, No. 33, 2013), endoplasmic reticulum stress played an important role in the hyperglycemia-induced death of ganglion cells and impairment of retinal microvessels.
Researchers from the Norwegian University of Science and Technology have had promising experimental results from using Botox as a weight loss tool in rats. The research group hopes to win approval for human testing in the near future.
A paper published in the Journal of Biomedical Optics (JBO), "Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining," demonstrates a potential new diagnostic option for catching a degenerative eye disease in its earliest stages.
› Verified 3 days ago
Casia Ravi, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39155 Liberty St Ste E500, Fremont, CA 94538 Phone: 510-574-2157 | |
Barbara Allen Maki, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39217 Liberty St Ste B-10, Fremont, CA 94538 Phone: 510-791-3322 Fax: 519-791-3325 | |
Rhondda Zude, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39155 Liberty St, Suite #e500, Fremont, CA 94538 Phone: 510-574-2100 | |
Benedicta Ott, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39155 Liberty St Ste E500, Fremont, CA 94538 Phone: 510-574-2100 | |
Sarita Mokha, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39155 Liberty St Ste E500, Fremont, CA 94538 Phone: 510-574-2100 | |
Mr. Frederic Morrison, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39803 Paseo Padre Pkwy Ste C, Fremont, CA 94538 Phone: 510-435-5326 Fax: 510-244-4787 | |
Graciela Molina Enriquez Fix, IMF Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 39184 State Street, Fremont, CA 94538 Phone: 510-456-3520 |